BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chan A, Kow A, Hibi T, Di Benedetto F, Serrablo A. Liver resection in Cirrhotic liver: Are there any limits? Int J Surg 2020;82S:109-14. [PMID: 32652296 DOI: 10.1016/j.ijsu.2020.06.050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Benedetti Cacciaguerra A, Görgec B, Lanari J, Cipriani F, Russolillo N, Mocchegiani F, Zimmitti G, Alseidi A, Ruzzenente A, Edwin B, D'Hondt M, Besselink MG, Giuliante F, Fuks D, Rotellar F, López-Ben S, Ferrero A, Aldrighetti L, Cillo U, Vivarelli M, Abu Hilal M. Outcome of major hepatectomy in cirrhotic patients; does surgical approach matter? A propensity score matched analysis. J Hepatobiliary Pancreat Sci 2021. [PMID: 34855277 DOI: 10.1002/jhbp.1087] [Reference Citation Analysis]
2 Hu Y, Fu T, Zhang Z, Hua L, Zhao Q, Zhang W. Does application of indocyanine green fluorescence imaging enhance clinical outcomes in liver resection? A meta-analysis. Photodiagnosis Photodyn Ther 2021;36:102554. [PMID: 34597831 DOI: 10.1016/j.pdpdt.2021.102554] [Reference Citation Analysis]
3 Mojtahed A, Núñez L, Connell J, Fichera A, Nicholls R, Barone A, Marieiro M, Puddu A, Arya Z, Ferreira C, Ridgway G, Kelly M, Lamb HJ, Caseiro-Alves F, Brady JM, Banerjee R. Repeatability and reproducibility of deep-learning-based liver volume and Couinaud segment volume measurement tool. Abdom Radiol (NY) 2022;47:143-51. [PMID: 34605963 DOI: 10.1007/s00261-021-03262-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Tautenhahn HM, Rauchfuß F, Ali Deeb A, Bauschke A, Settmacher U. [Living related liver transplantation]. Chirurg 2020;91:926-33. [PMID: 32909072 DOI: 10.1007/s00104-020-01268-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Chen X, Lu Y, Shi X, Chen X, Rong D, Han G, Zhang L, Ni C, Zhao J, Gao Y, Wang X. Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma. J Oncol 2021;2021:3002480. [PMID: 34925507 DOI: 10.1155/2021/3002480] [Reference Citation Analysis]
6 Wang J, Qiu Y, Yang Y, Shen S, Zhi M, Zhang B, Wang W. Impact of cirrhosis on long-term survival outcomes of patients with intrahepatic cholangiocarcinoma. Cancer Med 2022. [PMID: 35415945 DOI: 10.1002/cam4.4740] [Reference Citation Analysis]
7 Ma K, Que W, Hu X, Guo WZ, Gu EL, Zhong L, Morello V, Cazzanti M, Michieli P, Takahara T, Li XK. A Mesenchymal-epithelial transition factor-Agonistic Antibody Accelerates Cirrhotic Liver Regeneration and Improves Mouse Survival Following Partial Hepatectomy. Liver Transpl 2021. [PMID: 34529892 DOI: 10.1002/lt.26301] [Reference Citation Analysis]
8 Ekser B, Halazun KJ, Petrowsky H, Balci D. Liver transplantation and hepatobiliary surgery in 2020. Int J Surg 2020;82S:1-3. [PMID: 32698032 DOI: 10.1016/j.ijsu.2020.07.028] [Reference Citation Analysis]